dcsimg
Sun Oct 22, 2017 01:27
Login Password    Forgot password?    Member's Privilege  
 Advanced Search
   FEATURES:
   Oceanwide IR
   Gazette
   Learning
   Newsletter
   Info Center
Click here to toggle text size
Hao Le Ku (Beijing) Infant and Maternity Co., Ltd. Announces the Launch in Hong Kong of Halykoo ® Line Developed by the Swiss Company APR Applied Pharma Research
05 Oct 2017
Business Wire

Halykoo® baby healthcare consumer products are now available in Hong Kong, promoted and commercialized by the Chinese company Hao Le Ku (HLK), as a result of an exclusive partnership with APR Applied Pharma Research s.a. (“APR”), the Swiss, independent developer of science driven, patent protected healthcare products.

Hong Kong baby and child-specific products market is expected to grow at a CAGR of 2% in the next years, mainly driven by the local demand and a high per capita income. Hong Kong market is very dynamic with sophisticated consumers, historically used to international brands, being very sensitive to innovative and value added products as well as looking for brands which can offer them new meaningful experiences.

Halykoo® brand, the babies’ healthcare expert, matches the request coming from such a demanding market, as its science-driven solutions are the perfect combination of Swiss, high-quality pharmaceutical expertise with an extensive understanding of child and caregivers needs.

Halykoo® offers to parents a new way for the daily healthcare of their children, by turning a potentially stressful moment into a pleasant and rewarding experience, thanks to smart and innovative product deliveries intended to simplify their use for parents and reduce the hassle for babies.

In the first phase of launching, the distribution will focus mainly on baby and health stores that offer specialized health products and health counselling. In addition, HLK will start to build up their own online store, targeting young and highly-educated parents who are digital lovers with high purchasing power. Universal Health International Group Holding Limited has been appointed by HLK as the only distributor in Hong Kong and Macao district.

Supporting Halykoo® line at best for brand building and grapping a significant share of market, HLK has carried out a comprehensive media and communication campaign, with a specific focus on online marketing as well as social networks according to the digital mindset of the potential target. In addition, special promotions will be arranged in different distribution points through trained promoters, to introduce to young mothers Halykoo® products.

“We’re investing a lot on Halykoo® launch as we mean to build up a strong brand awareness and achieve a remarkable market share in the first year,” said Mr. Ricky Ren CEO of HKL. “We really want Halykoo® to be a great success in Hong Kong as this could be the stepping stone towards Great China.”

To celebrate the launch, HLK has participated to the 25th Eugene Baby Expo, one of the biggest international B2C baby-related exhibition, from 4th to 7th August in Wan Chai. The exhibition, held twice a year, had a record of over 500,000 visits and 800 exhibitors in average, thus being the perfect showcase for Halykoo® product range.

“We are very proud to see Halykoo® products on Hong Kong stores shelves – said Mr. Paolo Galfetti, CEO of APR – and we strongly believe that Halykoo® Swiss quality products will be soon appreciated by Hong Kong consumers, in a market where baby and child-specific products saw a steady growth in 2016. ”

About Halykoo®
Halykoo®, the babies’ healthcare expert, is the first global brand offering the most comprehensive range of consumer healthcare products. It matches formulations s specifically focused on each of the main stages of children’s growth, since birth, with smart and innovative deliveries intended to simplify their use for parents and reduce the hassle for babies.

The product range has been carefully developed to solve the main daily babies’ healthcare discomforts in the major therapeutic areas for turnover such as skin care, cough & cold, eye, ear & mouth and food supplementation. As of today, the portfolio includes over 18 already developed products and 10 additional products are under development to be finalized in 2018.

Conceived and formulated applying the value of Swiss pharmaceutical expertise, Halykoo provides science-driven pediatric solutions that perfectly combine smart deliveries, thanks to the application of the pharmaceutical technology knowledge, with advanced formulations, balanced on the physiological babies’ needs.

For more info about Halykoo®, please visit: www.halykoo.com

About Hao Le Ku (Beijing) Infant and Maternity Co., Ltd.
Hao Le Ku is a leading company engaged in marketing of baby products. We are a service oriented, high quality and ethically-driven. Our company was founded in 2013 and registered in Tian Jin, China. Our revenue has been increasing significantly during the last 2 years and the growth rate recorded is more than 100%. Our baby protection products covered many different categories in the industry.

About APR Applied Pharma Research s.a.
APR is a Swiss, independent developer of science-driven, patent protected healthcare products. The Company identifies, develops and licenses science- driven, value-added products designed to address patient or consumer needs in selected therapeutic areas on a global basis. Specifically, APR is currently focused on 2 (two) major areas: (i) internally developed and financed (alone or with our co-development partners) proprietary, value-added products to be licensed to healthcare companies for their commercialization, and (ii) support to third-party projects, by offering added value R&D services under contract and fee for service arrangements. APR has a balanced pipeline of revenue generating branded products commercialized in all major markets, combined with a compelling pipeline of products at different development stages. APR has entered into licensing and partnership agreements with pharmaceutical companies in over 70 countries with international sales on a worldwide basis.
For more information please visit www.apr.ch or www.halykoo.com

© Copyright Quamnet. All rights reserved. Republish the contents in whole or in part other than the authorized methods below, Quamnet reserves the right to proceed legal action.
Share :TwitThis   Facebook   LinkedIn       Forward to a friend
Latest News:
Fujitsu Partners with San Francisco Tech Council to Host Preserving Memories Event 21 Oct 2017
WORLD INDEX 21 Oct 2017
ASX-Listed Holista and Holista Foods Inc. (USA) Develop Breakthrough Noodle Formula with Low-Glycemic Score of 38; To Secure First Order Before End of 2017 21 Oct 2017
TOYOTA GAZOO Racing Ready to Attack the Welsh Forests 21 Oct 2017
DENSO Wins Medals at the 44th WorldSkills Competition 21 Oct 2017
RPA Platform Training Market - Rise in Blended Training to Drive Growth | Technavio 21 Oct 2017
Alipay Taps Marqeta to Expedite Payment Acceptance At Retail Locations Across the U.S. 21 Oct 2017
IoT in Warehouse Management - Market Segmentation and Growth Opportunities | Technavio 21 Oct 2017
Gelato Segment Leads the Frozen Desserts Market | Technavio 21 Oct 2017
APAC Leads the Decorative Paints and Coatings Market | Technavio 20 Oct 2017
Market Update
Watch List
Quamnet Research
Quammentary: Minsky Moment & Credit market cycles 20 Oct 2017
Golden Egg Portfolio & Conquest Fund: Asset switching 20 Oct 2017
First comment: Update on Datang Power (991)'s operating results in 3Q17 20 Oct 2017
PBOC’s supportive view on RMB, but……… 19 Oct 2017
Quammentary: Economic & industry aspects from the 19th National Congress 19 Oct 2017
Quamnet:

Help  |  Sitemap  |  About Us  |  Contact Us  |  Advertise with Us  |  Job Opportunities  |  Disclaimers  |  Privacy     
China Oceanwide International Financial Limited:
A founding member of:
MyQuamnet members get:
[Free Real Time Stock Quote] [Stock Charting Analysis] [Chart] [Hong Kong Stock Chart] [Industry Analysis] [Hong Kong Stocks Information] [Warrants] [CBBC] [Depositary Receipt] [Financial News] [Hong Kong Stock News] [US Stock News] [HKEx News] [New Stock] [Hong Kong Stocks Analysis] [Stocks Watch List] [Portfolio] [Finance Seminar] [Investment Seminar] [FOREX] [FX]
Quamnet Financial Services:
[Hong Kong Equity] [Hong Kong Stock] [Hong Kong Stock Quote] [Stock Quote] [Bid] [Ask] [Last Price] [Open] [Previous Close] [Board Lot] [Market Cap] [P/E] [P/B] [Real Time Price] [Past Prices] [Day High] [Day Low] [52 Week High] [52 Week Low] [Buy Ratio] [Sell Ratio] [Volume][Turnover] [Warrants Quote] [CBBC Quote] [Finance] [Stocks] [Investment] [Block Trades] [Chart Analysis] [Technical Indicator]
[Hong Kong Listed Companies Information] [Hong Kong Stocks Analysis] [HK Stock Quote] [Prospectus] [IPOs News] [Market Move News] [GEM] [Hang Seng Index] [HKCEI][Shenzhen A, B Index] [Shanghai A, B Index] [Hang Seng China AH Premium Index] [Forex] [Commodities Futures] [Gazette] [Commentary][Financial Columnists] [Fund House Report] [Shenzhen Stock Market] [Shanghai Stock Market] [Hong Kong Islamic Index] [Stock Trading Strategy] [Stock Monitoring Tools] [Commerce & Industry] [Financial] [Telecom, Media & Technology] [Conglomerates] [Healthcare] [Transportation] [Energy] [Property] [Utilities] [Global Alliance Partners] [Asset Management] [Securities Brokerage] [Personal Financial Advisory Solutions] [Futures] [US Stock] [ETFs] [HSI Futures] [Options] [Japanese yen] [US dollar] [Euro] [Pound sterling] [Australian dollar] [New Zealand dollar] [Canadian dollar]

Quamnet Subscription Services:
[Quam Research Main][Quam Research][Ask Quam][Columnists][Quam Wise][Market Move Signal] [Warrant Monitor][Investment Tools] [Quam Stock Monitor] [Stock Quote Ticker][Smart Database][Metastock][Quam Radar][Stable Growth Portfolio] [Aggressive Growth Portfolio][Fund Analysis][Wealth Management][Market Analysis] [Investment Base][Red Chip][H Stock][Bond][Mid - Short Term Stocks Investment Recommendations][Traders Corner][Rico][Mid - Short Term Investors][Traders Corner Portfolio][Stock Perspective][Newest Signal][Leader Trend][New Stock Pursuit][Smart Investor] [Smart Investor Adventurer Version] [Alex Wong] [Market Forecast][Pedder St Investor][Thomas Ng][Weekly Market Comment][Mid - Long Term Stocks & Investment Recommendations][IsaacsDaily] [Isaac] [Tony's collection][Value Perspective][Vincent Lam][Value Perspective upgraded version] [The Daily Perspective] [The Macro Perspective] [Market Oracle] [Henry Chan] [Economic Review] [Intelligent Observer] [Red Monkey][KL][Investment Monitoring List][FX Hunter] [Victor Ho] [Trading Comments][Invest Pro] [Paul Pong] [Global Market Analysis][Weekly Market Analysis][Virtual Stock Portfolio][Virtual Fund Portfolio] [Strategy updating] [Investment Strategy] [Sky Cheung]